Search consultations



Proposal from PHARMAC on meningococcal C conjugate vaccine

PHARMAC is seeking feedback on one final proposal for the supply and funding of meningococcal C conjugate vaccine. In summary, the proposal would result in:

  • Neisvac-C remaining as the only listed meningococcal C conjugate vaccine on the National Immunisation Schedule.
  • the delisting of Neisvac-C in the 10 injection pack presentation.
  • a correction of the chemical name for Neisvac-C in the Pharmaceutical Schedule.

The consultation can be found here:


Please send feedback to by Monday 5 June 2017.

Notify me when this page changes

Enter your email address below to receive alerts when this page is updated.

Sign up below to receive an email when we update this page

Enter the code shown above in the box below.